Biological sex and aging impact obesity development and type 2 diabetes, changing the secretion of leptin and adiponectin. The balance between these factors has been propounded as a reliable biomarker of adipose tissue dysfunction. Our proposal was to study sexual differences and aging on the adiponectin/leptin (Adpn/Lep) ratio in order to acquire a broader view of the impact of consuming an high-fat diet (HFD) on energy metabolism according to sex and age. Male and female C57BL/6J mice were fed a normal chow diet or an HFD for 12 or 32 weeks (n = 7–10 per group) and evolution of body weight, food intake and metabolic profile were registered. The HFD triggered an increase in body weight (p < 0.001), body weight gain (p < 0.01) and adiposity index (p < 0.01) in both sexes at 32 weeks of age, but female mice fed the HFD exhibited these changes to a significantly lower extent than males. Aged female mice showed an increase (p < 0.01) in the Adpn/Lep ratio, which was negatively correlated with body weight gain, changes in different fat depots and insulin resistance. Females were more metabolically protected from obesity development and its related comorbidities than males regardless of age, making the Adpn/Lep ratio a relevant factor for body composition and glucose metabolism.
Netrin (NTN)-1 exhibits pro- and anti-inflammatory roles in different settings, playing important roles in the obesity-associated low-grade chronic inflammation. We aimed to determine the impact of NTN-1 on obesity and obesity-associated type 2 diabetes, as well as its role in visceral adipose tissue (VAT) inflammation. A total of 91 subjects were enrolled in this case-control study. Circulating levels of NTN-1 and its receptor neogenin (NEO)-1 were determined before and after weight loss achieved by caloric restriction and bariatric surgery. mRNA levels of NTN1 and NEO1 were assessed in human VAT, liver, and peripheral blood mononuclear cells. In vitro studies in human visceral adipocytes and human monocytic leukemia cells (THP-1)-derived macrophages were performed to analyze the impact of inflammation-related mediators on the gene expression levels of NTN1 and its receptor NEO1 as well as the effect of NTN-1 on inflammation. Increased (p < 0.001) circulating concentrations of NTN-1 in obesity decreased (p < 0.05) after diet-induced weight loss being also associated with a reduction in glucose (p < 0.01) and insulin levels (p < 0.05). Gene expression levels of NTN1 and NEO1 were upregulated (p < 0.05) in the VAT from patients with obesity with the highest expression in the stromovascular fraction cells compared with mature adipocytes (p < 0.01). NTN1 expression levels were enhanced (p < 0.01) under hypoxia and by inflammatory factors in both adipocytes and macrophages. Adipocyte-conditioned media strongly upregulated (p < 0.001) the mRNA levels of NTN1 in macrophages. The treatment of adipocytes with NTN-1 promoted the upregulation (p < 0.05) of pro-inflammatory and chemotactic molecules as well as its receptor NEO1. Collectively, these findings suggest that NTN-1 regulates VAT chronic inflammation and insulin resistance in obesity.
Netrin (NTN)-1, an extracellular matrix protein with a crucial role in inflammation, is dysregulated during obesity (OB) and influences colon cancer (CC) progression. To decipher the mechanisms underlying CC development during obesity, we examined the expression of NTN1 and its receptors in the visceral adipose tissue (VAT) of 74 (25 normal weight (NW)) (16 with CC) and 49 patients with OB (12 with CC). We also evaluated the effect of caloric restriction (CR) on the gene expression levels of Ntn1 and its receptors in the colon from a rat model fed a normal diet. The impact of adipocyte-conditioned media (ACM) from patients with OB and NTN-1 was assessed on the expression levels of neogenin 1(NEO1), deleted in colorectal carcinomas (DCC) and uncoordinated-5 homolog B (UNC5B) in Caco-2 and HT-29 human colorectal cell lines, as well as on Caco-2 cell migration. Increased NTN1 and NEO1 mRNA levels in VAT were due to OB (p < 0.05) and CC (p < 0.001). In addition, an upregulation in the expression levels of DCC and UNC5B in patients with CC (p < 0.01 and p < 0.05, respectively) was observed. Decreased (p < 0.01) Ntn1 levels in the colon from rats submitted to CR were found. In vitro experiments showed that ACM increased DCC (p < 0.05) and NEO1 (p < 0.01) mRNA levels in HT-29 and Caco-2 cell lines, respectively, while UNC5B decreased (p < 0.01) in HT-29. The treatment with NTN-1 increased (p < 0.05) NEO1 mRNA levels in HT-29 cells and DCC (p < 0.05) in both cell lines. Finally, we revealed a potent migratory effect of ACM and NTN-1 on Caco-2 cells. Collectively, these findings point to increased NTN-1 during OB and CC fuelling cancer progression and exerting a strong migratory effect on colon cancer cells.
22 November 2022 in Journal of Physiology and Biochemistry
Biological sex differences have been observed in the development of obesity-related metabolic comorbidities. The aim was to determine the sex-specific response to high-fat diet (HFD) consumption on metabolic profile and adipose tissue dysfunction in male and female Wistar rats. 24 Wistar male and female rats were fed a normal chow diet or a HFD for 4 months. Body weight and food intake were periodically registered, and markers of the metabolic profile as well as the expression of inflammatory factors in visceral and subcutaneous adipose depots were measured. HFD-induced hyperphagia and weight gain were sexually dimorphic, with females displaying higher relative caloric intake (P < 0.001) but being protected against obesity and metabolic alterations, with significantly reduced (P < 0.001) body weight gain. The varying relationships of gene expression profiles with glucose homeostasis and inflammation biomarkers suggest that the different fat depots have distinct contributions to overall energy metabolism. Although female rats exhibited increased food intake and visceral adipose tissue hypertrophy, they were protected against HFD-induced obesity and exhibited better glucose homeostasis, indicating a metabolically healthy expansion of adipose tissue. Sexual differences in adipose tissue may have important implications for developing sex-specific therapeutic strategies for obesity and related metabolic disorders. Differences between males and females in the development of complications associated to obesity have been observed. Our study focuses on determining the sex differences in the response to a diet in metabolism and fat. Twenty-four Wistar rats-half male, half female-were given either a normal diet or a diet rich in fat for four months. Their body weight and how much they ate were checked regularly. The study also measured signs of metabolic health and how much certain inflammation-related substances were present in different types of fat from diverse regions. The results showed that males and females reacted differently to the high-fat diet. Even though female rats ate more calories compared to their body size, they did not gain as much weight as the males and were less likely to develop obesity or other metabolic problems. Female rats also had better glucose control. The study found that genes and inflammation markers were different in the fat tissues of males and females, suggesting that fat storage works differently in each sex. Even when female rats ate more, they stayed healthier and had better metabolism than male rats. These differences between males and females in how body fat works could be important for creating different treatments for obesity and related health problems for each sex.
Este ensayo describe la implementación y ejecución de “Cuéntame”, un proyecto de asistencia psicológica para el personal de la primera línea de acción en el contexto de la pandemia de Covid-19 en el Ecuador, que aún se mantiene vigente. Los principales objetivos del proyecto son reducir la brecha de acceso a servicios de salud mental para personal de la primera línea de acción, ofrecerles atención en salud mental a través de asistencia psicológica remota, y mitigar los efectos psicológicos negativos a corto y largo plazo en esta población. Se comentarán las principales barreras que surgieron durante el desarrollo del proyecto, y las potenciales soluciones que se siguen ejecutando. Finalmente, se concluirá discutiendo la relevancia e impacto de la iniciativa en torno a otras que puedan construirse a futuro en el ámbito de la salud mental, así como también testimonios de algunas de las partes involucradas en la implementación y ejecución.